Drug intelligence / Profile preview

cycloviolacin O15

Development stage
Preclinical
Modality
Peptides
01

Overview

Cycloviolacin O15 is a macrocyclic peptide belonging to the cyclotide family, originally isolated from the medicinal plant *Viola odorata*. It is characterized by a unique head-to-tail cyclic backbone and a knotted arrangement of three disulfide bonds, known as the cyclic cystine knot (CCK) motif. This structure provides the peptide with exceptional stability against thermal, chemical, and enzymatic degradation. A 2025 computational study utilizing virtual screening and molecular docking identified Cycloviolacin O15 as a potential inhibitor of the neuraminidase protein (specifically NanA) of *Streptococcus pneumoniae*. By targeting this enzyme, which is essential for bacterial adherence, colonization, and the degradation of host glycoconjugates, Cycloviolacin O15 is being explored as a novel therapeutic candidate for respiratory infections caused by this pathogen.

Other names
CyO15CyO-15CyO 15Cycloviolacin O15
02

Targets

NanA (Neuraminidase A)

Beyond the preview

Go deeper on cycloviolacin O15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cycloviolacin O15.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call